MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


IN BRIEF: NetScientific investee PDS Biotechnology posts widened loss

ALN

NetScientific PLC - London-based life sciences and sustainability technology investment firm - Reports second-quarter results from portfolio firm, PDS Biotechnology Corp. Net loss for three months to June 30 was $5.8 million, or $0.20 per basic share, widened from $600,000, or $0.03, a year before. ‘The higher net loss reported for the three months ended June 2022 is primarily due to additional costs for expansion of the company's research and development, including costs associated with our ongoing clinical trials, additional general and administrative costs, and lower income tax benefit,’ it says. PDS's cash balance at June 30 stands at $53.0 million. Netscientific holds 47% stake in PDS.

Current stock price: 64.00 pence

12-month change: down 45%

Copyright 2022 Alliance News Limited. All Rights Reserved.